Alaunos Therapeutics (WEK0) Ownership - Who Owns Alaunos Therapeutics?
Alaunos Therapeutics (WEK0) Ownership Overview
- 8.92% Insiders
- 1.56% Mutual Funds
- <0.01% Other Institutional Investors
- 0.39% ETFs
- 89.13% Public Companies and Individual Investors
The ownership structure of Alaunos Therapeutics (DE:WEK0) stock is a mix of institutional, retail, and individual investors. Approximately 1.95% of the company’s stock is owned by Institutional Investors, 8.92% is owned by Insiders, and 89.13% is owned by Public Companies and Individual Investors.
The ownership structure of Alaunos Therapeutics (DE:WEK0) stock is a mix of institutional, retail, and individual investors. Approximately 1.95% of the company’s stock is owned by Institutional Investors, 8.92% is owned by Insiders, and 89.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Robert W Postma | 142,878 | Insider | 3.95% | 159,166 |
| Jaime Vieser | 85,914 | Insider | 2.38% | 95,708 |
| Holger Weis | 49,047 | Insider | 1.36% | 54,638 |
| Michael Allen Jerman | 44,749 | Insider | 1.24% | 49,850 |
| Victory Portfolios Iii | 24,242 | Institution | 0.67% | 27,006 |
| Fidelity Concord Street Trust | 17,918 | Institution | 0.50% | 19,961 |
| Vanguard | 14,063 | Institution | 0.39% | 15,666 |
| Vanguard Index Funds | 14,063 | Institution | 0.39% | 15,666 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Victory Portfolios Iii | 24,242 | Institution | 0.67% | 27,006 |
| Fidelity Concord Street Trust | 17,918 | Institution | 0.50% | 19,961 |
| Vanguard Index Funds | 14,063 | Institution | 0.39% | 15,666 |
FAQ
Who Owns Alaunos Therapeutics (DE:WEK0)?
According to the latest TipRanks data, approximately 1.95% of the company's stock is held by institutional investors, 8.92% is held by insiders, and 89.13% is held by public companies and individual investors.
What percentage of Alaunos Therapeutics (DE:WEK0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.95% of Alaunos Therapeutics (DE:WEK0) stock is held by institutional investors: 1.56% by mutual funds, 0.39% by ETFs and <0.01% by other institutional investors.
What percentage of Alaunos Therapeutics (DE:WEK0) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.13% of Alaunos Therapeutics (DE:WEK0) stock is held by public companies and individual investors.
Who owns the most shares of Alaunos Therapeutics (DE:WEK0)?
Robert W Postma owns the most shares of Alaunos Therapeutics (DE:WEK0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.